Erasmus University Medical Center in Rotterdam, the Netherlands, is using Caliper Life Sciences' Sciclone NGS Workstation and Roche's NimbleGen SeqCap EZ Exome to automate exome capture and sequencing of more than 3,000 samples, the partners said this week.

The sequencing is being done as part of the Rotterdam Study, a large epidemiological study that includes 15,000 participants to identify genetic risk factors for age-related disorders such as osteoporosis, cardiovascular disease, Alzheimer disease, and type 2 diabetes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb or 360Dx Premium member?
Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.